AF-MSCs fate can be regulated by culture conditions

Cell Death and Disease

Volumn 4, Issue 4, 2013, Pages

  Zagoura, D S ^a,b   Trohatou, O ^a,b   Bitsika, V ^a,b   Makridakis, M ^b   Pappa, K I ^a   Vlahou, A ^b   Roubelakis, M G ^a,b   Anagnou, N P ^a,b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

AF MSCs; Culture conditions; Dedifferentiation; Differentiation; Transdifferentiation

Indexed keywords

GALECTIN 1; INITIATION FACTOR 3; NUCLEOSIDE DIPHOSPHATE KINASE A; OCTAMER TRANSCRIPTION FACTOR 4; PROHIBITIN; PROTEOME; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; VIMENTIN; BIOLOGICAL MARKER; REPRESSOR PROTEIN;

AMNION FLUID; ARTICLE; CELL CULTURE; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL FATE; CELL POPULATION; CELL PROLIFERATION; CELL THERAPY; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL; MESENCHYMAL STEM CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SECOND TRIMESTER PREGNANCY; TISSUE ENGINEERING; UPREGULATION; ADIPOCYTE; CHEMISTRY; CULTURE MEDIUM; CYTOLOGY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PREGNANCY;

ADIPOCYTES; AMNIOTIC FLUID; BIOLOGICAL MARKERS; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL TRANSDIFFERENTIATION; CULTURE MEDIA; FEMALE; GALECTIN 1; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEPATOCYTES; HUMANS; MESENCHYMAL STROMAL CELLS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; REPRESSOR PROTEINS; VIMENTIN;

EID: 84876931907     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.93     Document Type: Article

References (20)

1. Estey E, Döhner H. Acute myeloid leukaemia. Lancet 2006; 368: 1894-1907
2. Shih AH, Abdel-Wahab O, Patel JP, Levine RL. The role of mutations in epigenetic regulators in myeloid malignancies. Nat Rev Cancer 2012; 12: 599-612
3. Demonacos C, Krstic-Demonacos M, La Thangue NB. A TPR motif cofactor contributes to p300 activity in the p53 response. Mol Cell 2001; 8: 71-84
4. Adams CJ, Graham AL, Jansson M, Coutts AS, Edelmann M, Smith L et al. ATM and Chk2 kinase target the p53 cofactor Strap. EMBO Rep 2008; 9: 1222-1229
5. Demonacos C, Krstic-Demonacos M, Smith L, Xu D, O'Connor DP, Jansson M et al. A new effector pathway links ATM kinase with the DNA damage response. Nat Cell Biol 2004; 6: 968-976
6. Xu D, Zalmas LP, La Thangue NB. A transcription cofactor required for the heat-shock response. EMBO Rep 2008; 9: 662-669
7. Jansson M, Durant ST, Cho EC, Sheahan S, Edelmann M, Kessler B et al. Arginine methylation regulates the p53 response. Nat Cell Biol 2008; 10: 1431-1439
8. Davies L, Paraskevopoulou E, Sadeq M, Symeou C, Pantelidou C, Demonacos C et al. Regulation of glucocorticoid receptor activity by a stress responsive transcriptional cofactor. Mol Endocrinol 2011; 25: 58-71
9. Somervaille TCP, Matheny CJ, Spencer GJ, Iwasaki M, Rinn JL, Witten DM et al. Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells. Cell Stem Cell 2009; 4: 129-140
10. Somervaille TCP, Cleary ML. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. Cancer Cell 2006; 10: 257-268
11. Faiola F, Liu X, Lo S, Pan S, Zhang K, Lymar E et al. Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-Induced transcription. Mol Cell Biol 2005; 25: 10220-10234
12. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 69: 119-128
13. Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 2012; 483: 603-307
14. Allan R, Ratajczak T. Versatile TPR domains accommodate different modes of target protein recognition and function. Cell Stress Chaperones 2011; 16: 353-367
15. Juin P, Hueber AO, Littlewood T, Evan G. c-Myc-Induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev 1999; 13: 1367-1381
16. Blobel GA. CREB-binding protein and p300: Molecular integrators of hematopoietic transcription. Blood 2000; 95: 745-755
17. Rebel VI, Kung AL, Tanner EA, Yang H, Bronson RT, Livingston DM. Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. Proc Natl Acad Sci USA 2002; 99: 14789-14794
18. Karasuyama H, Melchers F. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur J Immunol 1988; 18: 97-104
19. Harris WJ, Huang X, Lynch JT, Spencer GJ, Hitchin JR, Li Y et al. The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells. Cancer Cell 2012; 21: 473-487
20. Somervaille TCP, Linch DC, Khwaja A. Different levels of p38 MAP kinase activity mediate distinct biological effects in primary human erythroid progenitors. Br J Haematol 2003; 120: 876-886